bendamustine sandoz 2,5 mg/ml proszek do sporządzania koncentratu roztworu do infuzji
sandoz gmbh - bendamustini hydrochloridum - proszek do sporządzania koncentratu roztworu do infuzji - 2,5 mg/ml
bendamustine kabi 2,5 mg/ml proszek do sporządzania koncentratu roztworu do infuzji
fresenius kabi polska sp. z o.o. - bendamustini hydrochloridum - proszek do sporządzania koncentratu roztworu do infuzji - 2,5 mg/ml
busulfan zentiva 6 mg/ml koncentrat do sporządzania roztworu do infuzji
zentiva, k.s. - busulfanum - koncentrat do sporządzania roztworu do infuzji - 6 mg/ml
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - chłoniak, mantle-cell - Środki przeciwnowotworowe - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).